BT-01-23
Проводит Bark Technology LLP
Страница компанииEvaluation of the Effectiveness and Safety of Vibro-acoustic Pulmonary Therapy (VAPT) in Complex Therapy for Acute Respiratory Failure of Mixed Type I-II Stages in Comparison With Percussion Massage in Cardiac Surgical Patients in the Early Postoperative Period
Источник: ClinicalTrials.gov (U.S. National Library of Medicine). Что откуда
Простыми словами
Словарь терминов- Статус исследования в реестре не указан — уточняйте в центре.
- Возраст участников: 18–80 лет. Остальные условия — в блоке «Кто может участвовать».
- По плану участвуют 310 чел. во всех странах исследования.
- Центров в реестре: 5 в 5 городах. Список — ниже на странице.
- Плановая дата окончания (09.2024) уже прошла.
Пересказ собран автоматически из данных реестра, без оценки пользы и рисков. Подробно о рисках и пользе рассказывает врач центра перед подписанием согласия.
Кто может участвовать
Главное из критериев
- Индекс массы тела18,5–35 кг/м²
Выбрано из текста реестра автоматически, по правилам — без ИИ. Решение об участии принимает врач центра по полному протоколу.
Полный текст критериев (на английском, как в ClinicalTrials.gov) · включение: 14 · невключение: 29
Критерии включения
- Age from 18 years to 80 years inclusive
- Body mass index from 18.5 to 35
- Physical status according to ASA II to ASA III (inclusive)
- Performed planned cardiac surgery (CS) under general anaesthesia with tracheal intubation and mechanical ventilation lasting more than 3 hours using a heart-lung machine (no more than 120 minutes)
- Left ventricular injection fraction before surgical treatment is above 40%
- Development of postoperative mixed ARF grade 1-2 (clinical criteria). SpO2 less than 95% with FiO2 21%.
- Stable-severe condition of the patient according to vital signs:
- stable hemodynamics (norepinephrine and/or adrenaline less than 0.15 mcg/kg/min, and/or dobutamine less than 10 mcg/kg/min, and/or no need for vasopressin (ADH) for 6 hours or more)
- absence of acute kidney injury (urine output more than 500 ml/day)
- stable respiratory dynamics.P/F more than 150 units, SpO2 more than 70% with FiO2 21%.Tracheal extubation within 8 hours of completion of surgery
- absence of critical coagulopathy (platelets more than 50 units/l)
- absence of acute cerebral insufficiency (GCS more than 12 points)
- absence of acute liver failure (bilirubin less than 30 units/l)
- Relieved postoperative pain syndrome and delirium (NRS less than 5 points, BPS less than 6 points, CAM-ICU (-), RASS -3-0 points).
Критерии невключения
- The presence of implanted or external medical electronic-mechanical devices in the impact projection (pacemaker, circulatory support devices, etc.);
- Severe hypocoagulation, risk of hematoma formation or bleeding in the projection of exposure;
- Severe hypercoagulation, risk of formation and/or migration of blood clots or emboli along the great vessels in the projection of exposure;
- Acute cerebrovascular accident (ACB), first 1-3 days;
- Cerebral Edema;
- High intracranial pressure;
- The presence of many purulent or burn wound surfaces in the projection of exposure;
- Presence of an unstable rib fracture;
- Pneumohemomediastinum and/or subcutaneous emphysema of the chest;
- Risk of development of hemo-pneumothorax;
- Osteomyelitis of the ribs and/or thoracic spine;
- Spinal fracture without orthopedic fixation;
- Trauma to the chest or abdomen with bleeding;
- High risk of seizures (CNS pathologies);
- The presence of an oncological process in the projection of exposure with destruction of tumor tissue and the risk of bleeding and/or metastasis;
- The presence of endothoracic and/or large endovascular implants (aortic stents, intra-aortic balloon pumps, endocardial catheters, mechanical heart valves, vena cava filters, subcutaneous venous ports, permanent hemodialysis devices);
- Heart rhythm disturbances (ventricular fibrillation, ventricular tachycardia);
- Hypovolemia;
- Disturbances of water-electrolyte balance and acid-base balance;
- Meningoencephalitis;
- Destructive purulent pneumonia;
- High risk of pulmonary hemorrhage;
- Hiatal hernia;
- Risk of dislocation of implanted drainage tubes and catheters;
- The presence of multiple wound surfaces in the projection of exposure;
- Severe bullous deformation of the lungs;
- Severe kyphoscoliosis;
- Spontaneous pneumothorax within the last year;
- Estimated systolic pressure over the pulmonary artery more than 50 mm Hg. Art.
Источник: ClinicalTrials.gov, NCT06320483 · запись обновлена в реестре 20 марта 2024.
Дизайн и результаты
Что измеряют — первичные конечные точки (7), вторичных — 14
- Partial pressure of oxygen (PaO2) — on days 2 and 3
- Partial pressure of carbon dioxide (PaCO2) — on days 2 and 3
- Blood oxygen saturation level (SpO2) on pulse oximeter (peripheral capillary oxygenation) — on days 2,3,4,5,6,7
- Ratio of peripheral arterial oxygen saturation(SaO2) to the inspired fraction of oxygen FiO2 — on days 2 and 3
- Ratio of venous saturation (SvO2) to the inspired fraction of oxygen FiO2 — on days 2,3,4,5,6,7
- ROX Index — on days 2 and 3
- P/F index (ratio of arterial blood PO2 to oxygen fraction) — on days 2 and 3
Цель исследования
The goal of this observational study is to evaluate the effectiveness and safety of vibro-acoustic pulmonary therapy (VAPT) in complex therapy for the acute respiratory failure of mixed type I-II stages in comparison with percussion massage in cardiac surgical patients in the early postoperative period.
Где проходит
5 центров в 5 городахОткуда эта информация
-
ClinicalTrials.gov (U.S. National Library of Medicine) · NCT06320483 Официальный реестр (США) · загружено 9 ноября 2026Номер протокола, название, цель, сроки, число участников, спонсор, центры
Сведения сведены и нормализованы порталом «Клиномир»: названия компаний и центров приведены к одному написанию. Нашли ошибку? Напишите нам — исправим.